Axumin PET-Guided Radiation Treatment Boosts Post-Prostatectomy Survival
christina.vines2020-11-04T14:02:42-05:00Lake Medical Imaging has been using Axumin PET/CT imaging to detect recurrent prostate cancer since Axumin became available in 2017.
Personal Risk Assessment Through Genetic Testing
christina.vines2020-12-22T13:04:55-05:00We are excited to announce we are now offering *genetic testing through Ambry Genetics® to our mammography patients. This is another way we’re helping women win the fight against breast cancer.
*Offered at select Lake Medical Imaging locations.
What Is Herd Immunity?
christina.vines2020-10-26T11:27:01-04:00Herd immunity occurs when a significant portion of a population becomes immune to an infectious disease, limiting further disease spread.
Webinar presented by Dr. Cathrine Keller – Lake Medical Imaging with Volpara and Ambry Genetics: Breast Screening
christina.vines2020-12-21T10:32:28-05:00https://www.youtube.com/watch?v=FLLdZdWLKd8
Colorectal Cancer Screening
christina.vines2020-09-28T16:38:41-04:00It is recommended that individuals age 50 and older receive routine screenings to increase their chances of survival. Lake Medical Imaging offers state-of-the-art diagnostic tools and minimally invasive Virtual Colonoscopy to detect polyps and cancerous cells at their most treatable stages.
An Innovative Test For Diagnosis Of Recurring Prostate Cancer
christina.vines2020-10-28T11:17:49-04:00Lake Medical Imaging offers an innovative test for diagnosis of recurring prostate cancer. Axumin™ (fluciclovine F 18) is a diagnostic agent used to enhance PET (Positron Emission Tomography) imaging in men who have suspected prostate cancer recurrence based on elevated PSA (prostate specific antigen) levels following treatment. Image courtesy of Blue Earth Diagnostics, Inc. [...]
